Exosens share falls below €59.15 and slips into the SBF 120 trough
The Bordeaux optronic company is declining mid-session in a lower-oriented Paris market. The movement extends Monday's decline and places it at the bottom of its index ranking.
A decline that brings the security below all its moving averages
The Exosens share is down 3.05% at €57.30, after losing 3.5% on Monday, placing it among the largest declines in the SBF 120, an index that is down 0.69% at the same time. The price is now below the 20-day MA at €59.15 (difference of 3.13%) as well as the 50-day MA at €59.38 (3.50%) and the 200-day MA at €60.25 (4.90%). The security thus falls back below its 200-day MA while it was still up 1.7% over three months. The support level at €54.15 is approximately 5.5% below the current price.
Over one week, the value declines 1%, but the quarter remains positive
Today's decline occurs in a tense market, where the CAC 40 is down 0.66% and the DAX loses 1.5%, while French debt remains under scrutiny three days before Moody's examination of the country's rating. Over one month, Exosens loses 5.5%, but it maintains a 29.2% gain over one year. The RSI at 51 is neutral and signals neither overbought nor oversold conditions. The next event is the publication of third quarter 2026 revenue, expected on October 27.
